FIRMAGON
Google image searchProduct monograph
Active ingredient
degarelix (degarelix acetate), 120 MG/VIAL
DIN: 02337037
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: SUBCUTANEOUS
Schedule: Prescription
Company: FERRING INC
Date: 24-NOV-2009
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02B — HORMONE ANTAGONISTS AND RELATED AGENTS (ATC, ATC/DDD)
- L02BX — Other hormone antagonists and related agents (ATC, ATC/DDD)
- L02BX02 — DEGARELIX (ATC/DDD)
Reference brand drug: Firmagon
Pharmaceutical standard: MFR
